» Articles » PMID: 35052885

Autoinducer Analogs Can Provide Bactericidal Activity to Macrolides in Through Antibiotic Tolerance Reduction

Overview
Specialty Pharmacology
Date 2022 Jan 21
PMID 35052885
Authors
Affiliations
Soon will be listed here.
Abstract

Macrolide antibiotics are used in treating chronic biofilm infections despite their unsatisfactory antibacterial activity, because they display several special activities, such as modulation of the bacterial quorum sensing and immunomodulatory effects on the host. In this study, we investigated the effects of the newly synthesized quorum-sensing autoinducer analogs (AIA-1, -2) on the activity of azithromycin and clarithromycin against . In the killing assay of planktonic cells, AIA-1 and -2 enhanced the bactericidal ability of macrolides against PAO1; however, they did not affect the minimum inhibitory concentrations of macrolides. In addition, AIA-1 and -2 considerably improved the killing activity of azithromycin and clarithromycin in biofilm cells. The results indicated that AIA-1 and -2 could affect antibiotic tolerance. Moreover, the results of hydrocarbon adherence and cell membrane permeability assays suggested that AIA-1 and -2 changed bacterial cell surface hydrophobicity and accelerated the outer membrane permeability of the hydrophobic antibiotics such as azithromycin and clarithromycin. Our study demonstrated that the new combination therapy of macrolides and AIA-1 and -2 may improve the therapeutic efficacy of macrolides in the treatment of chronic biofilm infections.

Citing Articles

Evaluation of Microbiological Susceptibility and Long-term Adhesive Properties to Dentin of Primers with Terminalia catappa Linn.

Lobao S, Nonato R, Moreira P, Mendonca A, Trovao M, Ferreira M J Adhes Dent. 2024; 26():103-116.

PMID: 38602234 PMC: 11740771. DOI: 10.3290/j.jad.b5199073.


and PA0065 Genes Are Responsible for Decreasing Antibiotic Tolerance by Autoinducer Analog-1 (AIA-1) in .

Pahlevi M, Murakami K, Hiroshima Y, Murakami A, Fujii H Antibiotics (Basel). 2022; 11(6).

PMID: 35740179 PMC: 9219673. DOI: 10.3390/antibiotics11060773.

References
1.
Murakami K, Ono T, Noma Y, Minase I, Amoh T, Irie Y . Explorative gene analysis of antibiotic tolerance-related genes in adherent and biofilm cells of Pseudomonas aeruginosa. J Infect Chemother. 2017; 23(5):271-277. DOI: 10.1016/j.jiac.2017.01.004. View

2.
Lamers R, Cavallari J, Burrows L . The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria. PLoS One. 2013; 8(3):e60666. PMC: 3609863. DOI: 10.1371/journal.pone.0060666. View

3.
Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M . Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax. 1995; 50(12):1246-52. PMC: 1021345. DOI: 10.1136/thx.50.12.1246. View

4.
Amoh T, Murakami K, Kariyama R, Hori K, Viducic D, Hirota K . Effects of an autoinducer analogue on antibiotic tolerance in Pseudomonas aeruginosa. J Antimicrob Chemother. 2017; 72(8):2230-2240. PMC: 6251570. DOI: 10.1093/jac/dkx132. View

5.
Favre-Bonte S, Kohler T, Van Delden C . Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother. 2003; 52(4):598-604. DOI: 10.1093/jac/dkg397. View